Lorbrena Interactions
There are 541 drugs known to interact with Lorbrena (lorlatinib), along with 8 disease interactions, and 3 alcohol/food interactions. Of the total drug interactions, 143 are major, 384 are moderate, and 14 are minor.
- View all 541 medications that may interact with Lorbrena
- View Lorbrena alcohol/food interactions (3)
- View Lorbrena disease interactions (8)
Most frequently checked interactions
View interaction reports for Lorbrena (lorlatinib) and the medicines listed below.
- acetaminophen
- acetaminophen / hydrocodone
- albuterol
- Alecensa (alectinib)
- Alimta (pemetrexed)
- Avastin (bevacizumab)
- benzonatate
- carboplatin
- cetirizine
- Compazine (prochlorperazine)
- folic acid
- furosemide
- gabapentin
- Horizant (gabapentin enacarbil)
- Lasix (furosemide)
- levothyroxine
- losartan
- melatonin
- metformin
- ondansetron
- potassium chloride
- rosuvastatin
- tramadol
- venlafaxine
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xalkori (crizotinib)
- Zofran (ondansetron)
- zoledronic acid
Lorbrena alcohol/food interactions
There are 3 alcohol/food interactions with Lorbrena (lorlatinib).
Lorbrena disease interactions
There are 8 disease interactions with Lorbrena (lorlatinib) which include:
- atrioventricular block
- CNS effects
- hepatotoxicity/hepatic impairment
- hyperglycemia
- hyperlipidemia
- hypertension
- interstitial lung disease
- severe renal impairment
Report options
More about Lorbrena (lorlatinib)
- Lorbrena consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
